Inflammation-related NFKB transcription factor rescues UPR-GS from miRNA-mediated suppression by directly inhibiting the expression of miR-29b/c upstream, thereby promoting UPR-related tumor aggressiveness and contributing to poor survival in bladder cancer patients. This evidence concerns the gene NFKB1 and urinary bladder carcinoma.